Press release
Global Artificial Intelligence In Drug Discovery Market to grow at a CAGR of 37.67% by 2032, Evaluates DelveInsight
DelveInsight's "Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence In Drug Discovery companies actively working in the market.
To know more about why North America is leading the market growth in the Artificial Intelligence In Drug Discovery market, get a snapshot of the report Artificial Intelligence In Drug Discovery Market Trends
https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Artificial Intelligence In Drug Discovery Overview
Artificial Intelligence (AI) in drug discovery refers to the use of advanced computational technologies-such as machine learning, deep learning, and data analytics-to accelerate and improve the process of identifying and developing new drugs. Traditionally, drug discovery is a long, expensive, and complex process, often taking over a decade and costing billions of dollars. AI helps reduce this time and cost by analyzing large datasets, predicting drug-target interactions, identifying potential drug candidates, repurposing existing drugs, and optimizing clinical trial designs.
AI can simulate how molecules behave, predict toxicity and efficacy, and even design new chemical structures that may work as future medicines. Major pharmaceutical companies and biotech startups increasingly rely on AI platforms to improve decision-making, reduce failure rates, and bring innovative therapies to market faster-especially in areas like oncology, rare diseases, and personalized medicine.
DelveInsight Analysis: The Artificial Intelligence (AI) in drug discovery market size is expected to grow at a CAGR of approximately 37.67% between 2025 and 2032.
Artificial Intelligence In Drug Discovery Market Insights
Geographically, North America is expected to generate the highest revenue in the AI in drug discovery market in 2023. This dominance is driven by a large patient population affected by conditions such as cancer and neurological disorders, creating a strong need for safer and more effective treatments. Additionally, the region benefits from a strong emphasis on clinical research and the presence of major pharmaceutical and technology companies, which collectively boost the adoption and advancement of AI-driven drug discovery solutions.
To read more about the latest highlights related to Artificial Intelligence In Drug Discovery, get a snapshot of the key highlights entailed in the Artificial Intelligence In Drug Discovery Market Insights
https://www.delveinsight.com/report-store/artificial-intelligence-ai-in-drug-discovery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Artificial Intelligence In Drug Discovery Market Report
• In May 2025, OpenAI met with officials from the FDA to discuss the use of AI in accelerating drug evaluations. The talks included discussions about a project called cderGPT, an AI tool for the FDA's Center for Drug Evaluation (CDE), which oversees prescription and over-the-counter drugs in the U.S. Representatives from Elon Musk's DOGE were also reportedly involved in the discussions.
• In May 2024, Sanofi, Formation Bio, and Open AI entered into a collaboration to develop AI-powered software aimed at accelerating drug development and enhancing the efficiency of bringing new medicines to patients. Together, they aimed to create customized, purpose-built solutions designed to optimize various stages of the drug development lifecycle, thereby streamlining processes and improving outcomes in pharmaceutical innovation.
• In July 2023, Insilico Medicine announced the first drug discovered and designed by generative AI into Phase II clinical trials with patients. This lead program, for a potentially first-in-class pan-fibrotic inhibitor known as INS018_055 - is Insilico's moonshot drug one that demonstrates beyond a doubt the validity of Insilico's end-to-end AI drug discovery.
• In January 2022, Sanofi entered into a research collaboration with Exscientia, which uses artificial intelligence to discover new drug candidates that could be worth up to USD 5.2 billion for the latter company.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Intelligence In Drug Discovery market during the forecast period
Key Players in the Artificial Intelligence In Drug Discovery Market
Some of the key market players operating in the Artificial Intelligence In Drug Discovery market include- IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, and others.
Which MedTech key players in the Artificial Intelligence In Drug Discovery market are set to emerge as the trendsetter explore @ Key Artificial Intelligence In Drug Discovery Companies
https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Artificial Intelligence In Drug Discovery Market Landscape
Given these benefits, AI-powered de novo drug design is set to emerge as a major focus in drug discovery in the near future. Its ability to speed up the development timeline and create novel molecular candidates is expected to play a crucial role in expanding the market. As more pharmaceutical companies integrate AI into their research workflows, its influence on drug discovery and development will deepen, fostering breakthroughs and unlocking new possibilities for treatment innovation throughout the 2025-2032 forecast period.
Scope of the Artificial Intelligence In Drug Discovery Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Intelligence In Drug Discovery Market Segmentation By Product Type: De Novo Drugs Design and Optimization, Preclinical Testing, and Others
• Artificial Intelligence In Drug Discovery Market Segmentation By Application: Oncology, Cardiovascular, Infection Disease, and Others
• Artificial Intelligence In Drug Discovery Market Segmentation By End-User: Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others
• Artificial Intelligence In Drug Discovery Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Intelligence In Drug Discovery Companies: IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Artificial Intelligence In Drug Discovery market will grow by 2032? Click to get a snapshot of the Artificial Intelligence In Drug Discovery Market Analysis
https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Artificial Intelligence In Drug Discovery Market to grow at a CAGR of 37.67% by 2032, Evaluates DelveInsight here
News-ID: 4251616 • Views: …
More Releases from DelveInsight Business Research
Global Antidote Market to reach USD 4,007.09 million growing at a CAGR of 7.13% …
According to DelveInsight's analysis, The antidote market is expanding rapidly, largely due to the growing cases of poisoning, drug overdoses, and increased incidents of snake and animal bites. This rising demand is supported by greater public health awareness, government programs aimed at overdose prevention and treatment, and continuous advancements in antidote development. Moreover, new product launches and innovations by major industry players addressing toxic exposures are further strengthening market growth.…
Stargardt Disease Market to Witness Promising Upswing by 2034, DelveInsight Fore …
The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products will significantly revolutionize the Stargardt Disease market dynamics.
DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United…
Global Structural Heart Devices Market to grow at a CAGR of 10.08% to reach USD …
According to DelveInsight's analysis, The Structural Heart Devices market is the growing prevalence of cardiovascular and valvular diseases, such as aortic stenosis, mitral regurgitation, and congenital heart defects, which is increasing the demand for advanced treatment options. Additionally, the rising preference for minimally invasive cardiac procedures offering faster recovery, fewer complications, and shorter hospital stays-is accelerating the adoption of transcatheter-based devices. Continuous technological advancements, including next-generation heart valves and repair…
Global Vein Illumination Devices Market to grow at a CAGR of 4.13% to reach USD …
According to DelveInsight's analysis, The vein illumination devices market is projected to experience strong and consistent growth, largely due to the increasing burden of chronic illnesses like cardiovascular diseases and cancer. These conditions, along with factors such as aging populations and rising obesity rates, are driving the need for more efficient venous access methods. Moreover, the surge in global blood donation activities, combined with rapid technological progress and ongoing innovations…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
